Abstract

Enormous resources are being invested in genetics, neuroscience and nanotechnology in search vital processes that might provide effective treatment for genetic and severe degenerative disorders, but these goals are still distant. Institutional and military resources are being poured into biotechnological developments for behavioral intervention and cognitive and moral enhancement for persons with difficulties as well as for healthy individuals. Enhancement will increase health and empowerment inequities to the detriment of the disadvantaged. Marked inequality in Latin America calls for an urgent focus on the compromised values at play in biotechnological interventions that will be unavailable to those in need.